Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system

被引:0
|
作者
Yi Gao
机构
关键词
Acute liver failure; Animal model; Bioartificial liver; Micro-capsulized activated carbon adsorbing; Porcine hepatocyte;
D O I
暂无
中图分类号
R575.3 [肝功能衰竭];
学科分类号
1002 ; 100201 ;
摘要
AIM: To establish a highly reproducible animal model of acute liver failure (ALF), for assessing the effect of bioartificial liver support system (BALSS). METHODS: A two-phase complete liver devascularization procedure was performed in eight loco-hybrid pigs. Blood biochemical index and liver biopsy were studied every 2 h after surgery, and survival time was recorded. The BALSS constructed with high volume recirculating technique was a hollow fiber circulating system consisting of a hepatocyte reactor-hollow fiber module inoculated with microcarrieradhering hepatocytes, and a double pump, heparinized, thermostabilized, micro-capsulized activated carbonadsorbing plasmapheresis system. Twelve pigs undergoing two-phase surgery were randomized into: control group (perfused without hepatocytes, n=6) and treatment group (perfused with hepatocytes, n=6). Intergroup liver biochemical indexes, survival time, and liver pathological changes were analyzed at regular intervals. RESULTS: Two-phase surgery was performed in all the experimental pigs, and there was no obvious difference between their biochemical indexes. After 3 h of phase II surgery, ammonia (Amm) increased to (269±37) |umol/L. After 5 h of the surgery, fibrinogen (Fib) decreased to (1.5±0.2) g/L. After 7 h of the surgery, ALT, AST, Tbil and PT were (7.6±1.8) nka/L, (40±5) nka/L, (55±8) nmol/L and (17.5±1.7) nka/L respectively. After 9 h of surgery, ALB and Cr were (27±4) g/L and (87±9) nmol/L. After 13 h of surgery, BUN was (3.5±0.9) μmol/L. All the above values were different from those determined before surgery. Survival time of pigs averaged 13.5±1.4 h. ALF pigs in the other group were treated with BALSS. The comparison analysis between the treated and control animals showed the changes of Tbil, PT, Alb, BUN, Cr, Fib, and Amm (P<0.01), but there was no change of ALT and AST. The survival time was statistically different (P<0.01), and there was no significant difference in histological changes. CONCLUSION: The porcine ALF model established by two-phase devascularized surgery is valid and reproducible. The hollow fiber BALSS can meet the needs of life support and is effective in treating ALF.
引用
收藏
页码:5468 / 5474
页数:7
相关论文
共 50 条
  • [21] Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure
    Zhang, Zhi
    Zhao, Yi-Chao
    Cheng, Yuan
    Jian, Guo-Deng
    Pan, Ming-Xin
    Gao, Yi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (46) : 17399 - 17406
  • [22] Study of porcine hepatocyte-entrapped bioartificial liver in surgery-induced fulminant hepatic failure rabbits
    Lin, Chi-Chang
    Wang, Chih-Chi
    Hung, Kuo-Chen
    Chen, Chao-Long
    Yong, Chee-Chien
    Young, Tai-Horng
    Kobayash, Eiji
    BIOCHEMICAL ENGINEERING JOURNAL, 2013, 76 : 55 - 59
  • [23] An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure
    Ytrebo, LM
    Nedredal, GI
    Langbakk, B
    Revhaug, A
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (09) : 1077 - 1088
  • [24] Porcine model of auxiliary partial orthotopic liver transplantation for acute liver failure
    Fukueda, Mikio
    Ishizaki, Naoki
    Hamada, Nobuo
    Kadono, Jun
    Kaieda, Mamoru
    Nakamura, Noboru
    Komokata, Teruo
    Sakata, Ryuzou
    TRANSPLANTATION, 2006, 82 (10) : 1312 - 1318
  • [25] Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients
    Morsiani, E
    Pazzi, P
    Puviani, AC
    Brogli, M
    Valieri, L
    Gorini, P
    Scoletta, P
    Marangoni, E
    Ragazzi, R
    Azzena, G
    Frazzoli, E
    Di Luca, D
    Cassai, E
    Lombardi, G
    Cavallari, A
    Faenza, S
    Pasetto, A
    Girardis, M
    Jovine, E
    Pinna, AD
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2002, 25 (03) : 192 - 202
  • [26] Follow-up by one- and two-dimensional NMR of plasma from pigs with ischemia-induced acute liver failure treated with a bioartificial liver
    Tréhout, D
    Desille, M
    Doan, BT
    Mahler, S
    Frémond, B
    Mallédant, Y
    Campion, JP
    Desbois, J
    Beloeil, JC
    Certaines, J
    Clément, B
    NMR IN BIOMEDICINE, 2002, 15 (06) : 393 - 403
  • [27] Novel spheroid reservoir bioartificial liver improves survival of nonhuman primates in a toxin-induced model of acute liver failure
    Li, Yi
    Wu, Qiong
    Wang, Yujia
    Weng, Chengxin
    He, Yuting
    Gao, Mengyu
    Yang, Guang
    Li, Li
    Chen, Fei
    Shi, Yujun
    Amiot, Bruce P.
    Nyberg, Scott L.
    Bao, Ji
    Bu, Hong
    THERANOSTICS, 2018, 8 (20): : 5562 - 5574
  • [28] Artificial Liver Support System in Acute Liver Failure Patients Waiting Liver Transplantation
    Montejo Gonzalez, Juan C.
    Catalan Gonzalez, Mercedes
    Meneu Diaz, Juan C.
    Moreno Elola-Olaso, Almudena
    De la Cruz, Javier
    Moreno Gonzalez, Enrique
    HEPATO-GASTROENTEROLOGY, 2009, 56 (90) : 456 - 461
  • [29] Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia
    Al-Chalabi A.
    Matevossian E.
    von Thaden A.
    Schreiber C.
    Radermacher P.
    Huber W.
    Perez Ruiz de Garibay A.
    Kreymann B.
    Intensive Care Medicine Experimental, 5 (1)
  • [30] Non-bioartificial artificial liver support system in acute liver failure: A comprehensive systematic review and meta-analysis of randomized controlled trials
    Shi, Ruizhi
    Hui, Xu
    Tong, Ting
    Li, Junfeng
    Zhang, Liting
    Yang, Kehu
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (02)